Gulf Pharmaceutical Industries P.S.C. (ADX: JULPHAR)

Market Cap	1.59B
Revenue (ttm)	1.71B
Net Income (ttm)	-23.00M
Shares Out	1.16B
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	138.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,776,823
Open	1.450
Previous Close	1.450
Day's Range	1.400 - 1.460
52-Week Range	0.730 - 1.780
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About JULPHAR

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and other pharmaceutical, medical, cosmetic compounds in the United Arab Emirates, other GCC countries, and internationally. It operates through Manufacturing, Plant, Investment, and Others segment. The company provides generic medicines for pain management, GIT and endocrine, antiviral, respiratory, anti-infectives, cardio care, wound care, dermatology, CNS and psychiatry, biotechnology, gynecology women care, anemia, antibiotics, in...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 2,400
• Stock Exchange: Abu Dhabi Securities Exchange
• Ticker Symbol: JULPHAR

Financial Performance

In 2023, JULPHAR's revenue was 1.64 billion, an increase of 1.36% compared to the previous year's 1.62 billion. Losses were -99.10 million, 237.1% more than in 2022.